Pretherapy platelet-to-lymphocyte ratio as a prognostic parameter for locally advanced hypopharyngeal cancer patients treated with radiotherapy combined with chemotherapy

被引:0
作者
Meng Wan
Dan Zhao
Weixin Liu
Zhou Huang
Xiaolong Xu
Baomin Zheng
Shaowen Xiao
Yan Sun
Weihu Wang
机构
[1] Peking University Cancer Hospital and Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology
来源
European Archives of Oto-Rhino-Laryngology | 2022年 / 279卷
关键词
Hypopharyngeal carcinoma; Radiotherapy; Platelet-to-lymphocyte ratio; Local failure; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5859 / 5868
页数:9
相关论文
共 198 条
[1]  
Kuo P(2014)Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States Laryngoscope 124 2064-2069
[2]  
Chen MM(2019)Epidemiology of Hypopharyngeal Cancer Adv Otorhinolaryngol 83 1-14
[3]  
Decker RH(2009)National Cancer Database report on cancer of the head and neck: 10-year update Head Neck 31 748-758
[4]  
Yarbrough WG(2008)The natural history of patients with squamous cell carcinoma of the hypopharynx Laryngoscope 118 1362-1371
[5]  
Judson BL(2014)Pattern of cervical lymph node metastasis in medial wall pyriform sinus carcinoma Laryngoscope 124 882-887
[6]  
Bradley PJ(2006)Management of contralateral N0 neck in pyriform sinus carcinoma Laryngoscope 116 1268-1272
[7]  
Cooper JS(2018)Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands Eur Arch oto-rhino-laryngol. 275 181-189
[8]  
Porter K(2015)Survival trends in hypopharyngeal cancer: a population-based review Laryngoscope 125 624-629
[9]  
Mallin K(2009)Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation Ann Oncol 20 921-927
[10]  
Hoffman HT(2013)Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group J Clin Oncol 31 2854-2860